Immune Tolerance

The unit aims to develop cell-therapeutic methods and antibody-based therapeutic strategies (immuno-oncology) for the treatment of hematologic-oncologic diseases (e.g. leukemia) and complications resulting from hematopoietic stem cell transplantations (e.g. Graft-versus-Host-Disease, GvHD). The unit also explores innovative therapeutic approaches for the prevention of infections, especially those caused by multiresistant pathogens in the case of transplantations. New immune tolerance concepts are also tested in models developed by the unit, with regard to immunological and therapy-associated complications.



Here we show you a selection of current projects.


We work closely with partners from science and industry. Find out more here.


Here you will find an overview of all publications that have emerged from the research work of our unit.